INSIGHTS ON PHARMACEUTICAL PACKAGING
-
Autoinjectors For Autoimmune Diseases: Benefits And Considerations
By improving convenience, ensuring precise dosing, and reducing dependency on healthcare facilities, autoinjectors enhance patient outcomes and quality of life.
-
Stability Issues Unique To Liquid Injectables And How To Avoid Them
Liquid injectables face stability risks like oxidation, hydrolysis, aggregation, temperature shifts, and packaging effects, requiring early, rigorous formulation and process controls.
-
Form Fill And Seal Label Applicator For Drug Packaging
Discover a solution that ensures particularly efficient and reliable vertical and horizontal form fill and seal machine labeling.
-
Evaluating The Entire Package System Under USP 382
USP 382 introduces holistic packaging evaluation, focusing on container closure integrity, functionality, and real-world conditions to ensure sterility, safety, and product reliability.
-
How Adept Formulation Helps Overcome Manufacturability Challenges6/17/2026
Initial development, scaleup, and tech transfer of complex multi-particulate drug systems requires meticulous planning to mitigate manufacturing risks.
-
FAQs On The Revised EU GMP Annex 1: Volume 23/5/2025
Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.
-
PCI Pharma Services Capabilities Update January 2026: Fill/Finish1/27/2026
Patricia Krainski highlights PCI’s global sterile fill‑finish and lyophilization strengths, showcasing investments that expand capacity, technologies, and integrated solutions for complex biologics, formulations, and lyophilized products.
-
What To Look For In A Pharma Contract Packaging Partner2/27/2026
Teams face rising pressure around compliance, complexity, and speed. These five essential qualities help identify packaging partners who can support production, reduce risk, and align with your needs.
-
Integrated Solutions Mitigating Challenges PosedBy RNA-Based Drugs7/2/2026
Safeguard RNA drug stability with an integrated manufacturing strategy. Combining specialized analytics, advanced packaging, and precision assembly ensures molecular integrity and efficient production.
PHARMACEUTICAL PACKAGING SOLUTIONS
-
Glass plays a crucial role in protecting drug integrity and the performance of any parenteral injection device. By continually perfecting the forming process, we have become a leading producer of high-quality, high-value, ready-to-use, primary packaging for drug delivery systems.
-
Final packing machines are designed for a gently transfer of the containers from the annealing oven to trays or blisters, minimizing the need for human operators and reducing the risk of contamination or human error. A five-position rotary table acts as a buffer and extends the system’s autonomy.
-
Decades of experience in production technologies, quality control and knowledge of the regulatory environment result in high-quality drug delivery devices that are fully optimized to perform as a system.
-
AST's Vial Sealing System (VSS) is a benchtop, semi-automatic machine used for sealing or capping pharmaceutical vials and bottles with aluminum caps. The VSS provides complete and precise control of the container sealing or capping operations to ensure the highest quality vial seal. The system’s versatility allows for the processing of a wide range of vial or bottle sizes and finishes and is ideal for small batch processing of sterile pharmaceutical and biotechnology products.
-
Contract packaging for pharmaceutical and consumer health care is Ropack’s core service. Global customers rely on our exacting production environments — 32 Class 100000 Clean Rooms, including a new dedicated stick-pack production facility ensuring low RH and controlled temperature.